A

ATAI Life Sciences NV
D

ATAI

3.80000
USD
0.09
(2.43%)
مغلق
حجم التداول
78,423
الربح لكل سهم
-0
العائد الربحي
-
P/E
-5
حجم السوق
1,380,215,488
المقالات

العنوان: AtaiBeckley Inc

القطاع: Healthcare
الصناعة: Biotechnology
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.